|
|
|
|
|
|
by Spivak
1315 days ago
|
|
|
Patients seldom have a choice in any aspect of their care. We could flood the market with dirt cheap insulin using an older formulation but surprise you can’t actually do that without one of the oligarchs buying your company just to stop you. |
|
|
There is nothing stopping Congress from passing a bill to fund insulin R&D that provides the newest insulin technology without being patented, but the fact that they do not and would rather sit in their pulpit and “grill” private company representatives proves that it is all a show.
We (sufficient voters) want to pay for nothing, but expect everything.